Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas.

Abstract

Plasma OPN levels appeared to correlate with tumor hypoxia in HNSCC patients and may serve as noninvasive tests to identify patients at high risk for tumor recurrence.